CervoMed (CRVO) Q4 2024 Annual Earnings
CRVO·Reported March 17, 2025·Before market open
CervoMed reported Q4 2024 revenue of $2.2M, beat analyst consensus of $1.5M by $620.5K. Diluted EPS came in at $-0.80, missed the $-0.67 consensus by $0.13.
Revenue
$2.2Mbeat by $620.5K
Consensus: $1.5MDiluted EPS
$-0.80missed by $0.13
Consensus: $-0.67
Financial Snapshot
Trailing eight quarters through Q4 2024
Q4 2024 Earnings FAQ
Common questions about CervoMed's Q4 2024 earnings report.
CervoMed (CRVO) reported Q4 2024 earnings on March 17, 2025 before market open.
CervoMed reported revenue of $2.2M and diluted EPS of $-0.80 for Q4 2024.
Revenue beat the consensus estimate of $1.5M by $620.5K. EPS missed the consensus estimate of $-0.67 by $0.13.
You can read the 10-K periodic report (0001437749-25-007829) directly on SEC EDGAR. The filing index links above go to sec.gov.